Claire S. Padgett
Technik-/Wissenschafts-/F&E-Leiter bei REGULUS THERAPEUTICS INC.
Aktive Positionen von Claire S. Padgett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REGULUS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.11.2022 | - |
Karriereverlauf von Claire S. Padgett
Ehemalige bekannte Positionen von Claire S. Padgett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MIRATI THERAPEUTICS | Corporate Officer/Principal | - | 01.10.2018 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2012 | 01.10.2018 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Geschäftsführer | - | 28.09.2010 |
Technik-/Wissenschafts-/F&E-Leiter | 28.09.2010 | 01.06.2011 | |
ONCOLYTICS BIOTECH INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.04.2012 | - |
Corporate Officer/Principal | 11.11.2011 | 24.04.2012 | |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Claire S. Padgett
Seton Hall University | Graduate Degree |
Rutgers State University of New Jersey | Undergraduate Degree |
Capella University LLC | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONCOLYTICS BIOTECH INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Claire S. Padgett
- Erfahrung